Study of the Intradermal Injection of rHuPH20 or Placebo in Subjects With Nickel Allergic Contact Dermatitis
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect and safety of rHuPH20 or placebo for the
treatment of skin allergic reaction to nickel. The study drug and placebo will be
administered by intradermal injection.